Concepta PLC New manufacturing facility in Doncaster (5809O)
November 08 2016 - 1:09AM
UK Regulatory
TIDMCPT
RNS Number : 5809O
Concepta PLC
08 November 2016
8 November 2016
Concepta plc ("Concepta" or "the Company")
New manufacturing facility in Doncaster
Concepta plc (AIM:CPT), the UK healthcare company targeting the
personalised mobile health market with a primary focus on women's
fertility, is pleased to announce that it has signed a 10 year
lease for its new manufacturing facility in Doncaster, Yorkshire.
The addition of this new facility will provide the Company with the
necessary capacity and economies of scale as it pushes ahead with
the launch of its MyLotus product for unexplained infertility* into
China in Q4 2016 and, following CE marking, into the UK and Europe
in 2017.
The newly built 6,000sqft premises are at the Bullrush Grove
Business Park and will employ 8 full-time staff over time together
with ad-hoc temporary staff when needed. The facility will be used
to manufacture lateral flow test strips for the Company's MyLotus
product. The site has office-space already fitted and the Company
is now establishing the manufacturing, warehousing and Quality
Control areas. The site will be fully operational in Q1 2017 and
has significant capacity for further expansion.
Concepta will situate all of its customer-facing roles at the
new Doncaster facility, whilst its recently opened laboratory site
in Colworth, Bedfordshire will continue as the Company's primary
R&D base.
Erik Henau, CEO says: "We are pleased to have signed the lease
on this excellent location for our UK manufacturing operations.
Concepta has a commitment to Yorkshire through one of the earliest
backers of our business: Finance Yorkshire. The securing of this
new facility is essential to the Company's continued growth and it
will provide the capacity to support our flagship MyLotus fertility
product following its targeted launch in China later this year and
across Europe in 2017.
"Additionally, following the recent opening of our state of the
art research and development hub in Bedfordshire, the Company is
well positioned for new product development in the wider mobile
health space and we look forward to updating the market on further
exciting developments in due course."
ENDS
Enquiries:
The Company
Adam Reynolds, Chairman
Tel: +44 (0) 7785 908158
SPARK Advisory Partners Limited (Nomad)
Neil Baldwin/Mark Brady
Tel: +44 (0)20 368 3550
Beaufort Securities Limited (Broker)
Jon Belliss
Tel: +44 (0)20 7382 8300
Yellow Jersey PR Limited (Financial PR)
Felicity Winkles/ Joe Burgess
Tel: +44 (0) 7748 843 871
About Concepta Plc:
Concepta plc is a pioneering UK healthcare company that has
developed a proprietary platform and products targeted at the
personalised mobile health market with a primary focus on women's
fertility and specifically unexplained infertility*.
Founded in 2013, Concepta has developed a revolutionary flagship
product 'MyLotus' for home self-testing that helps women with
unexplained infertility to conceive.
MyLotus is the only consumer product which allows both
quantitative and qualitative measurements of measurement of a
woman's personal hCG and LH hormone levels in an easy to use home
test to facilitate higher conception rates and early diagnosis of
any fertility problems. Competitor products currently only allow
qualitative measurement and are based on the 'average woman'.
Concepta has a defined route to market for its new 'My Lotus'
product with Regulatory approvals for launch in China in place for
2016 and CE-Marking for UK and Europe to follow in 2017 where the
revenue potential of the Chinese and EU infertility market is worth
c.GBP600m per annum for the company.
*Unexplained infertility refers to women that have been unable
to conceive after 6 months of trying. This highly motivated target
group of consumers won't typically be offered medical intervention
until 12 months of unsuccessfully trying, with IVF not offered
until two years. Research indicates couples start to take positive
action ahead of this time and there is little medical support to
help them do so.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCUWRBRNBAARRA
(END) Dow Jones Newswires
November 08, 2016 02:09 ET (07:09 GMT)
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2024 to May 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From May 2023 to May 2024